Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Lauren Kaplan illuminates the problematic issues in the life experiences of people living with HIV. She focuses on the challenges embedded in social policy such as access, cost and availability of quality medical care as well as immigration policies, which can restrict the freedom of people to travel, work, and live in different nations and regions. Another focus are stigma, discrimination as well as existential struggles of identity, meaning, and reality. By engaging in a transnational comparison, the author identifies areas of strength and weakness in domestic U.S. policy as compared to social policies in Germany.  Contents Financial Freedom and Autonomy Stigma: Appearance, Privacy, and Visibility Migration Experiences: Asylum Seeker Social Policy and Barriers to U.S. Travel Reversal of Agency: Denial and the Construction of Alternate Reality Target Groups Researchers and students from the fields of sociology, public health, and psychology Practitioners and policy makers in health care The Author Lauren Kaplan completed her doctoral dissertation at the Goethe University Frankfurt am Main. She is now a research officer in the Department of Social Policy and Intervention at Oxford University.

Social sciences (general) --- Qualitative methods in social research --- Sociology --- HIV infecties --- sociologie --- sociale wetenschappen --- levenskwaliteit

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

HIV continues to be a profound challenge facing communities nationally and internationally.  Until a vaccine or a cure is found, prevention remains a most crucial line of defense. However, the successes made to reduce exposure and transmission have not benefited all communities equally. HIV continues to affect vulnerable communities, and HIV-related health disparities are growing.  The work documented in Innovations in HIV Prevention Research and Practice through Community Engagement spotlights the effectiveness of community involvement to reduce HIV infections in the United States. This timely resource introduces the concepts of community engagement, partnership, and community-based participatory research (CBPR). Contributors provide detailed examples of these concepts in which diverse research partners blend their unique insights and skills to arrive at an authentic understanding of phenomena and inform the translation of best practices and processes to enhance equity in HIV prevention and treatment. Equitable interactive collaboration is central to these efforts, in which community members and representatives from organizations, the scientific and medical sectors, and other relevant agencies nurture long-term health improvement through sustained teamwork. Challenges and barriers to effective engagement are identified, as are characteristics of successful partnerships. Included in the book: Details of a multigenerational HIV prevention intervention in a rural southeastern community. The challenges and successes of developing, implementing, and evaluating an intervention for higher-risk predominately heterosexual black men in college. The history of gay community involvement in HIV prevention and its contributions to the theory and current practice of engagement. Next steps in the integration of HIV-related policy change and research. Community engagement within American Indian communities. Keys to sustaining a CBPR partnership to prevent HIV within ethnic, sexual, and gender minority communities.  Innovations in HIV Prevention Research and Practice through Community Engagement offers researchers and practitioners in public health, community health, and medicine guidance on community engagement that is both inspiring and realistic.  “Community engagement and knowledge continue to be essential to prevent HIV infections.  This book is a compilation of the state-of-the-science of engagement and delves deeper into the meaning and utilization of community-based participatory research, with implications that reach beyond the HIV epidemic to public health and medicine in general.” -          Laura C. Leviton, PhD, Senior Advisor for Evaluation, Robert Wood Johnson Foundation, Princeton, NJ  .

Psychology --- Sociology --- Hygiene. Public health. Protection --- Psychiatry --- HIV infecties --- medische psychologie --- preventieve gezondheidszorg --- sociologie --- gezondheidspromotie --- LGBTQIA+ (lesbian, gay, bi, trans, queer, intersex and asexual) --- vaccinatie

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book explores a number of issues related to the stigma arising from HIV/AIDS infection, perceived or actual discrimination from the community and society, and the extent of vulnerabilities for infected Asian refugees and immigrants. It assesses the health care and treatment regimen for HIV/AIDS accessed by immigrants and refugee claimants in North America, including treatments offered by the health-care system and ethnic communities, and their perceptions and biases relating to HIV/AIDS issues. On another level, the book identifies the ways in which HIV-sufferer immigrants and refugees/refugee claimants from Asia are vulnerable to discrimination due to 1) lack of information about HIV/AIDS incidence in the community; 2) inability of the health system to respond appropriately; and 3) the community’s need for introspection on their own health issues. This book reveals the dynamics that influence choice, behavior, and lifestyle of HIV sufferer immigrants, adds to the existing knowledge about refugees and migrants, and proposes a unified theory of discrimination and stigmatization within the context of human rights. In addition, the book presents a number of policy recommendations based on empirical findings with a view to helping reshape polices regarding refugee HIV sufferers and their social ramifications. This book will be of interest to researchers and students in any field from social sciences, health and psychology, as well as practitioners in the field of development and public policy. The book will be beneficial to policy formulators and implementers engaged in addressing the serious threat emanating from the HIV/AIDS pandemic.

International relations. Foreign policy --- Human rights --- Public administration --- Hygiene. Public health. Protection --- HIV infecties --- volksgezondheid --- mensenrechten --- AIDS (acquired immune deficiency syndrome) --- internationale betrekkingen --- administratie

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The association between AIDS and cancer was recognized from the beginning ofthe AIDS epidemic, when the appearance of Kaposi sarcoma in a cluster of youngmen was one of the first signs of this new disease. It was soon recognized that AIDSpatients are prone to develop a number of “AIDS-defining” cancers: Kaposi sarcoma,lymphoma, and cervical cancer. The development of effective combination anti-HIVtherapy starting around 1996 converted AIDS from a death sentence to a manageabledisease and led to dramatic shifts in the epidemic. As this therapy was able to improveimmune function in patients, the incidence of most “AIDS-defining” cancers decreased.There is a misconception, however, that AIDS has gone away. In fact, as AIDS patientsare living longer, the number of AIDS patients has more than doubled in the UnitedStates since 1996, and the AIDS population overall has increased in age. Also, as AIDSpatients are less likely to die of other complications, cancer is coming to the forefront as one of the most common causes of death in regions where AIDS drugs are widelyavailable.Moreover, the three “AIDS-defining” cancers are now taking a back seat toa number of other HIV-associated cancers, such as Hodgkin lymphoma, lung cancer,and anal cancer. In the developing world, AIDS-associated cancers are a major publichealth problem, and in some regions of sub-Saharan Africa, Kaposi sarcoma is themost common tumor in men. In recent years, there has been a vast increase in our understanding of HIV-associatedcancers. We now know, for example, that most are caused by other viruses and thatthe main role of HIV and immunodeficiency is to provide a supportive environmentfor the viruses to multiply and for the cancers to develop. But there remain a numberof unanswered questions and a need for improved prevention and therapy. In the 28chapters of this book, written by some of the most renowned experts in this field, wepresent up-to-date information on the cancers associated with HIV infection. Thechapters cover the epidemiology of these cancers, as well as their pathogenesis, clinicalpresentation, and treatment. Dr. Robert Yarchoanis the Director of the Office of HIV and AIDS Malignancy andChief of the HIV and AIDS Malignancy Branch in the National Cancer Institute. Heplayed a major role in developing the first AIDS drugs. His research is now focused onAIDS-related cancers, especially Kaposi sarcoma and other cancers caused by Kaposisarcoma-associated herpesvirus.

Immunology. Immunopathology --- Oncology. Neoplasms --- Medical microbiology, virology, parasitology --- Pathological biochemistry --- Infectious diseases. Communicable diseases --- Human medicine --- immunologie --- HIV infecties --- tumoren --- medische biochemie --- medische virologie --- biochemie --- biomedische wetenschappen --- virologie --- oncologie --- besmettelijke ziekten --- AIDS (acquired immune deficiency syndrome)

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

One of the most promising new approaches for the prevention of HIV transmission, particularly for developing countries, involves topical, self-administered products known as microbicides. The development of microbicides is a long and complicated process, and this volume provides an overview of all the critical areas, from the selection of appropriate candidate molecules and their formulation, preclinical and clinical testing for safety and efficacy, strategies for product registration and finally, issues associated with product launch, distribution and access. The book will prove valuable to both those working in the field and all others who are interested in learning more about this product class, which has the potential to significantly impact the future of this devastating epidemic.

Immunology. Immunopathology --- Pharmacology. Therapy --- Medical microbiology, virology, parasitology --- Pathological biochemistry --- Human medicine --- vaccins --- HIV infecties --- klinische chemie --- medische biochemie --- medische virologie --- farmacologie --- biochemie --- biomedische wetenschappen --- virologie --- vaccinatie --- moleculaire biologie